Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer

The BET bromodomain protein BRD4 is a chromatin reader that regulates transcription, including in cancer. In prostate cancer, specifically, the anti-tumor activity of BET bromodomain inhibition has been principally linked to suppression of androgen receptor (AR) function. MYC is a well-described BRD...

Descripción completa

Detalles Bibliográficos
Autores principales: Coleman, Daniel J., Gao, Lina, Schwartzman, Jacob, Korkola, James E., Sampson, David, Derrick, Daniel S., Urrutia, Joshua, Balter, Ariel, Burchard, Julja, King, Carly J., Chiotti, Kami E., Heiser, Laura M., Alumkal, Joshi J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405739/
https://www.ncbi.nlm.nih.gov/pubmed/30846826
http://dx.doi.org/10.1038/s41598-019-40518-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405739/
https://www.ncbi.nlm.nih.gov/pubmed/30846826
http://dx.doi.org/10.1038/s41598-019-40518-5

Ejemplares similares